[HTML][HTML] Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges

HR Wardill, LT Wooley, OM Bellas, K Cao… - British Journal of …, 2024 - nature.com
The side effects of cancer therapy continue to cause significant health and cost burden to the
patient, their friends and family, and governments. A major barrier in the way in which these …

[HTML][HTML] Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn't

C Christensen, M Rose, C Cornett, M Allesø - Biomedicines, 2023 - mdpi.com
The 'entourage effect'term was originally coined in a pre-clinical study observing
endogenous bio-inactive metabolites potentiating the activity of a bioactive …

Changes in prescribed opioid dosages among patients receiving medical cannabis for chronic pain, New York State, 2017-2019

T Nguyen, Y Li, D Greene, S Stancliff… - JAMA Network …, 2023 - jamanetwork.com
Importance Patients with chronic pain often receive long-term opioid therapy (LOT), which
places them at risk of opioid use disorder and overdose. This presents the need for …

Cannabinoid 1 and mu-opioid receptor agonists synergistically inhibit abdominal pain and lack side effects in mice

Y Yu, QK Tsang, J Jaramillo-Polanco… - Journal of …, 2022 - Soc Neuroscience
While effective in treating abdominal pain, opioids have significant side effects. Recent
legalization of cannabis will likely promote use of cannabinoids as an adjunct or alternative …

Delta‐9‐tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: a within‐subject, randomized …

JP De Aquino, J Meyerovich, CZ Xie… - Addiction …, 2023 - Wiley Online Library
The opioid and cannabinoid receptor systems are inextricably linked—overlapping at the
anatomical, functional and behavioural levels. Preclinical studies have reported that …

Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study

L Bapir, S Erridge, M Nicholas, M Pillai… - Expert review of …, 2023 - Taylor & Francis
Introduction There is growing evidence on the efficacy of cannabis-based medicinal
products (CBMPs) for chronic pain (CP). Due to the interaction between CP and anxiety, and …

Cannabidiol drug interaction considerations for prescribers and pharmacists

M Graham, JH Martin, CJ Lucas, B Murnion… - Expert Review of …, 2022 - Taylor & Francis
Introduction In light of the widespread use of non-prescribed and prescribed cannabidiol, the
use of cannabidiol with other medications is likely, and this may result in drug interactions …

[HTML][HTML] Cannabinoids for Acute Pain Management: Approaches and Rationale

MO Botea, L Andereggen, RD Urman… - Current pain and …, 2024 - Springer
The scientific basis for supporting the use of cannabis is extensive, although it does not
necessarily translate into relevant clinical outcomes. The use of cannabinoids in acute pain …

[HTML][HTML] Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults …

CM Campbell, CJ Mun, KR Hamilton… - …, 2023 - nature.com
The potential synergistic effects of combining cannabinoids and opioids for analgesia has
received considerable attention. No studies to date have evaluated this combination in …

Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy

DJ Farkas, ZD Cooper, LN Heydari… - Cannabis and …, 2023 - liebertpub.com
Introduction: Chronic neuropathic pain is as a severe detriment to overall quality of life for
millions of Americans. Current pharmacological treatment options for chronic neuropathic …